Hayek Kallen Investment Management
Position in AVXL — Anavex Life Sciences Corp.
CIK 1430681
FAIRHOPE, AL
Position in AVXL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$144,624
+$36,908 QoQ
Shares Held
47,109
+289.2% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Hayek Kallen Investment Management holds $251,417 across 2 Biotechnology names. AVXL ranks #1 (57.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVXL |
Anavex Life Sciences Corp.
This page
|
47,109 | $144,624 | |
| 2 | CRMD |
CorMedix Inc.
|
15,728 | $106,793 |
All Filings in AVXL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $144,624 | 47,109 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $107,716 | 12,103 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $111,589 | 12,103 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $102,119 | 11,902 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $127,827 | 11,902 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $67,381 | 11,863 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $50,061 | 11,863 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $57,634 | 11,323 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $99,365 | 10,673 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||